E117: Inebilizumab for IgG4-RD (MITIGATE)
Dec 03, 2024•13 min•Ep. 118
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
New RCT in a new disease with a new drug! But is it as shiny as one would hope? Interesting discussion today about what a trial means, how it will affect practice, and how we could do better as a field. Happy holidays everyone!
For the best experience, listen in Metacast app for iOS or Android